Article
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters.
European journal of cancer (Oxford, England : 1990) - 1 Nov 2022
Rimini Margherita, Loi Eleonora, Fabregat-Franco Carles, Burgio Valentina, Lonardi Sara, Niger Monica, Scartozzi Mario, Raposelli Ilario G, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Rizzato Mario, Nichetti Federico, Lai Eleonora, Cappetta Alessandro, Macarulla Teresa, Fassan Matteo, De Braud Filippo, Pretta Andrea, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Zavattari Patrizia, Casadei-Gardini Andrea
Abstract excerpt
BACKGROUND: IDH1-mutated intrahepatic cholangiocarcinomas (IDH1m iCCAs) could be treated with anti-IDH1 drugs, although the high heterogeneity in this class of tumours could limit treatment efficacy. METHODS: We selected 125 IDH1m iCCAs that were treated as resectable, locally advanced, or metastatic and were screened by the NGS-based FoundationOne gene panel. We conducted a mutation-based clustering of tumours...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
